Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electroacupuncture for CINV in Breast Cancer
NCT06314906Phase 3Recruiting
- Start
- Mar 2024
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms). Primary endpoint: Proportion of Patients Free from Nausea Throughout Treatment at 120 hours. Started Mar 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06314906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06314906.